Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

Federica Riccardo; Maddalena Arigoni; Genny Buson; Elisa Zago; Manuela Iezzi; Dario Livio Longo; Matteo Carrara; Alessandra Fiore; Simona Nuzzo; Silvio Bicciato; Patrizia Nanni; Lorena Landuzzi; Federica Cavallo; Raffaele Calogero; Elena Quaglino

首页> 外文期刊>BMC Genomics >Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

【24h】

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

机译：肺癌的遗传小鼠模型的表征：鉴定非小细胞肺癌治疗靶标和生物标志物的承诺

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BMC Genomics》 |2014年第3期|共页
作者
Federica Riccardo; Maddalena Arigoni; Genny Buson; Elisa Zago; Manuela Iezzi; Dario Livio Longo; Matteo Carrara; Alessandra Fiore; Simona Nuzzo; Silvio Bicciato; Patrizia Nanni; Lorena Landuzzi; Federica Cavallo; Raffaele Calogero; Elena Quaglino;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医学遗传学;
关键词

相似文献

外文文献
中文文献
专利

1. hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression [J] . Michael G. Edwards, Katherine Vandervest, John Arcaroli, Biology Open . 2013,第7期

机译：hsa-miR29b（非经典Wnt信号的关键下游靶标）通过靶向MDM2表达在非小细胞肺癌细胞中发挥抗增殖作用hsa-miR29b（非经典Wnt信号的关键下游靶标）通过靶向MDM2表达在非小细胞肺癌细胞中的抗增殖作用hsa-miR29b（非经典Wnt信号的关键下游靶点）通过靶向MDM2表达在非小细胞肺癌细胞中发挥抗增殖作用
2. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation [J] . ChungC., ChristiansonM. Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2014,第1期

机译：具有乳腺癌，结肠直肠癌和非小细胞肺癌治疗靶点的预测性和预后性生物标志物：对当前进展，证据和建议的系统评价
3. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model [J] . Suo-fu YE, Jian LI, Shuang-min JI, 中国药理学报：英文版 . 2017,第002期

机译：乙二胺在人非小细胞肺癌异种移植小鼠模型中抗癌作用的剂量生物标志物反应模型
4. Development and Evaluation of CD44- Targeted Lipid-Based Nanoparticles in an Orthotopic Non-Small Cell Lung Cancer Xenograft Mouse Model [C] . Amy E. Webster, J. Christopher Luft, Joseph M. DeSimone American Chemical Society Division of Polymeric Materials Science and Engineering Conference . 2015

机译：在原位非小细胞肺癌异种移植小鼠模型中CD44-靶向脂质基纳米粒子的发展与评价
5. Genetic Cooperation in BRAF(V600E)-induced Non-Small Cell Lung Cancer Using Genetically Engineered Mouse Models of Cancer. [D] . Juan, Joseph. 2015

机译：使用癌症的基因工程小鼠模型进行BRAF（V600E）诱导的非小细胞肺癌的遗传合作。
6. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers [O] . Federica Riccardo, Maddalena Arigoni, Genny Buson, 2014

机译：肺癌的遗传小鼠模型的表征：鉴定非小细胞肺癌治疗靶标和生物标志物的承诺
7. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers [O] . Federica Riccardo, Maddalena Arigoni, Genny Buson, 2014

机译：肺癌的遗传小鼠模型的表征：鉴定非小细胞肺癌治疗靶标和生物标志物的承诺

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

著录项

相似文献

相关主题

期刊订阅